Schroedermason0459
DNA extracted from formalin-fixed, paraffin-embedded tissue sections is often inadequate for sequencing, due to poor yield or degradation. We optimized the proteinase K digest by testing increased volume of enzyme and increased digest length from the manufacturer's protocol using 54 biospecimens, performing the digest in centrifuge tubes. Doubling the quantity of proteinase K resulted in a median increase in yield of 96%. Applying the optimized proteinase K protocol to sections deparaffinized on microscope slides generated a further increase in yield of 41%, but only at >50,000 epithelial tumor cells/section. DNA yield now correlated with (χ2 = 0.84) and could be predicted from the epithelial tumor cell number. DNA integrity was assayed using end point multiplex PCR (amplicons of 100-400 bp visualized on a gel), quantitative PCR (qPCR; Illumina FFPE QC Assay), and nanoelectrophoresis (DNA Integrity Numbers [DINs]). Generally, increases in yield were accompanied by increases in integrity, but sometimes qPCR and DIN results were conflicting. Amplicons of 400 bp were almost universally obtained. The process of optimization enabled us to reduce the percentage of samples that failed published quality control thresholds for determining amenability to whole genome sequencing from 33% to 7%.Carbapenemase-producing Enterobacteriaceae (CPE) have been very rarely reported in companion animals in South Korea. In this study, we aimed to investigate the molecular characteristics and relatedness of two New Delhi metallo-β-lactamase (NDM-5)-producing Escherichia coli isolates from rectal swabs of a dog and a cat hospitalized in different veterinary hospitals in South Korea during 2019. Antimicrobial susceptibility was tested by the Etest and broth microdilution method. PCR and sequencing were performed to detect antimicrobial resistance genes. Plasmid replicon typing and Southern blotting hybridization were performed to determine the replication origin of the plasmid and location of the blaNDM-5 gene, respectively. Their macrorestriction profiles for E. coli isolates were assessed by multilocus sequence typing (MLST) and pulse-field gel electrophoresis (PFGE). The two carbapenem-resistant E. coli isolates harbored the blaNDM-5 gene located on the IncX3 plasmid. Allele sequence analysis for MLST showed that the two E. coli isolates were attributed to sequence type 410 (ST410). The NDM-5-producing E. coli isolate from the cat presented high clonal similarity (94%) assessed by PFGE to a previously reported NDM-5-producing E. coli ST410 isolate from a dog hospitalized in the same hospital in 2017. The two E. coli isolates for the genetic environment surrounding the blaNDM-5 gene had the same structure ISAba125-blaNDM-5-bleMBL-trpF-TAT-ISCR26. This study revealed a direct transmission of the NDM-5-producing E. coli ST410 isolate between a dog and a cat. This is the first report of NDM-5 carbapenemase-producing E. coli isolate from a cat in South Korea.Transcripts of the Tuesday Lessons at La Salpêtrière Hospital show that Jean-Martin Charcot often asked his patients about their family history. The information gathered on patients' heredity played also a significant role in the diagnostic reasoning he instructed his students in. Again and again, he included in his teachings the concept of degeneration to suggest an etiology for observed pathologies. Crenolanib This article analyzes the origin of Charcot's knowledge, imparted in the Tuesday Lessons, by examining the theories of heredity and degeneration successively developed by Prosper Lucas (1808-1885) in 1847, Bénédict-Auguste Morel (1809-1873) in 1857, and Jacques-Joseph Moreau de Tours (1804-1884) in 1859. I will review examples taken from the Tuesday Lessons to illustrate how Charcot assimilated the ideas of these alienists. Two of his students, Charles Féré (1852-1907) and Georges Gilles de la Tourette (1857-1904), known for championing their master's work, went on to publish their own books that developed theories of heredity and degeneration. I will conclude my review, which aims to examine a little known facet of Charcot's work, with a few examples from these authors' writings.In this study, we sought to evaluate the clinical feasibility of indocyanine green (ICG)-guided sentinel lymph node (SLN) sampling during robotic retroauricular neck dissection (RAND) in patients with cN0 oral cancer. Nine adult patients diagnosed with T1 to T2 oral squamous cell carcinoma were consecutively recruited. All of them underwent transoral partial glossectomy and robotic RAND (levels I-III) simultaneously. Twelve hours prior to surgery, ICG was injected into the 4 quadrants around primary tongue tumors. During robotic RAND, intraoperative and ex vivo ICG-stained LNs were identified using the Firefly system and examined for the presence of fluorescence. ICG-stained LNs were identified in all patients. Thirty-one ICG-stained LNs were detected in 313 retrieved LNs (9.9%). Occult metastases were detected among the ICG-stained LNs in 2 patients (22.2%). There was no metastasis identified in the ICG-unstained LNs. Upstaging rates, sensitivity, specificity, and negative predictive value of ICG-guided SLN sampling were 22.2%, 100%, 91.5%, and 100%, respectively.Inotersen, a 2'-O-methoxyethyl (2'-MOE) phosphorothioate antisense oligonucleotide, reduced disease progression and improved quality of life in patients with hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN) in the NEURO-TTR and NEURO-TTR open-label extension (OLE) trials. However, 300 mg/week inotersen treatment was associated with platelet count reductions in several patients. Mean platelet counts in patients in the NEURO-TTR-inotersen group remained ≥140 × 109/L in 50% and ≥100 × 109/L in 80% of the subjects. However, grade 4 thrombocytopenia ( less then 25 × 109/L) occurred in three subjects in NEURO-TTR trial, and one of these suffered a fatal intracranial hemorrhage. The two others were treated successfully with corticosteroids and discontinuation of inotersen. Investigations in a subset of subjects in NEURO-TTR (n = 17 placebo; n = 31 inotersen) and OLE (n = 33) trials ruled out direct myelotoxicity, consumptive coagulopathy, and heparin-induced thrombocytopenia. Antiplatelet immunoglobulin G (IgG) antibodies were detected at baseline in 5 of 31 (16%) inotersen-treated subjects in NEURO-TTR, 4 of whom eventually developed grade 1 or 2 thrombocytopenia while on the drug.